Logo-apb
Adv Pharm Bull. 2016;6(4): 581-587. doi: 10.15171/apb.2016.072
PMID: 28101465        PMCID: PMC5241416

Research Article

Nanostructured Lipid Carrier for Topical Application of N-Acetyl Glucosamine

Lavin Aliasgharlou 1, Saeed Ghanbarzadeh 2, Hamideh Azimi 3, Mohammad Hossein Zarrintan 4, Hamed Hamishehkar 5 *

Cited by CrossRef: 15


1- Fitriani E, Avanti C, Rosana Y, Surini S. Nanostructured lipid carriers: A prospective dermal drug delivery system for natural active ingredients. PHAR. 2024;71:1 [Crossref]
2- Czajkowska-Kośnik A, Szekalska M, Winnicka K. Nanostructured lipid carriers: A potential use for skin drug delivery systems. Pharmacological Reports. 2019;71(1):156 [Crossref]
3- Aryani N, Siswodihardjo S, Soeratri W, Sari N. Development, characterization, molecular docking, and in vivo skin penetration of coenzyme Q10 nanostructured lipid carriers using tristearin and stearyl alcohol for dermal delivery. 2021;32(4):517 [Crossref]
4- Hatem S, El Hoffy N, Elezaby R, Nasr M, Kamel A, Elkheshen S. Background and different treatment modalities for melasma: Conventional and nanotechnology-based approaches. Journal of Drug Delivery Science and Technology. 2020;60:101984 [Crossref]
5- Banna H, Hasan N, Lee J, Kim J, Cao J, Lee E, Moon H, Chung H, Yoo J. In vitro and in vivo evaluation of MHY908-loaded nanostructured lipid carriers for the topical treatment of hyperpigmentation. Journal of Drug Delivery Science and Technology. 2018;48:457 [Crossref]
6- M. A, Sudheer P, Sogali B. Nanostructured Lipid Carrier-Mediated Transdermal Delivery System of Glibenclamide for Gestational Diabetes: Pharmacokinetic and Pharmacodynamic Evaluation. CDD. 2024;21(10):1386 [Crossref]
7- Marto J, Sangalli C, Capra P, Perugini P, Ascenso A, Gonçalves L, Ribeiro H. Development and characterization of new and scalable topical formulations containing N-acetyl-d-glucosamine-loaded solid lipid nanoparticles. Drug Development and Industrial Pharmacy. 2017;43(11):1792 [Crossref]
8- Bevanahally V, Shende P. Nanostructured Lipid Carriers for Skin Depigmentation: A Modulated Aspect in Cosmetics. COSCI. 2022;1(2) [Crossref]
9- Zoabi A, Touitou E, Margulis K. Recent Advances in Nanomaterials for Dermal and Transdermal Applications. Colloids and Interfaces. 2021;5(1):18 [Crossref]
10- Vaziri M, Tayarani-Najaran Z, Kabiri H, Nasirizadeh S, Golmohammadzadeh S, Kamali H. Preparation and Characterization of Undecylenoyl Phenylalanine Loaded-Nanostructure Lipid Carriers (NLCs) as a New α-MSH Antagonist and Antityrosinase Agent. Adv Pharm Bull. 2023;13(2):290 [Crossref]
11- Zhou X, Hao Y, Yuan L, Pradhan S, Shrestha K, Pradhan O, Liu H, Li W. Nano-formulations for transdermal drug delivery: A review. Chinese Chemical Letters. 2018;29(12):1713 [Crossref]
12- H. Moglad E, Fatima F, Muqtader A M, Devanathad V, Khalid Anw M, F. Aldawsa M. Development of Topical Antibacterial Gel Loaded with Cefadroxil Solid Lipid Nanoparticles: In vivo Wound Healing Activity and Epithelialization Study. International J of Pharmacology. 2020;16(4):298 [Crossref]
13- Waghule T, Rapalli V, Gorantla S, Saha R, Dubey S, Puri A, Singhvi G. Nanostructured Lipid Carriers as Potential Drug Delivery Systems for Skin Disorders. CPD. 2020;26(36):4569 [Crossref]
14- Singh S, Sharma N, Zahoor I, Behl T, Antil A, Gupta S, Anwer M, Mohan S, Bungau S. Decrypting the Potential of Nanotechnology-Based Approaches as Cutting-Edge for Management of Hyperpigmentation Disorder. Molecules. 2022;28(1):220 [Crossref]
15- Salvi V, Pawar P. Nanostructured lipid carriers (NLC) system: A novel drug targeting carrier. Journal of Drug Delivery Science and Technology. 2019;51:255 [Crossref]
16- Bhattacharyya S. In vitro/In vivo Evaluation of Elastic Nano-lipid Carriers of Aztreonam for Pneumonic Lungs. PNT. 2023;11(3):294 [Crossref]
17- Hajipour H, Ghorbani M, Kahroba H, Mahmoodzadeh F, Emameh R, Taheri R. Arginyl-glycyl-aspartic acid (RGD) containing nanostructured lipid carrier co-loaded with doxorubicin and sildenafil citrate enhanced anti-cancer effects and overcomes drug resistance. Process Biochemistry. 2019;84:172 [Crossref]